Kelsey C. Hewitt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kelsey C. Hewitt has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Daniel L. Drane
Department of Neurology, School of Medicine Emory University Atlanta Georgia USA
5 shared publications - Cady K. Block
Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
4 shared publications David W. Loring
Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA
3 shared publications- David W. Loring
Department of Neurology, Emory University School of Medicine, Atlanta, USA
3 shared publications Abdulrahman Alwaki
Department of Neurology Emory University School of Medicine Atlanta GA USA
2 shared publications- Genevieve Rayner
Department of Neurology Alfred Hospital Melbourne Victoria Australia
2 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186
From potential to practice: An International survey on technology adoption and needs in epilepsy neuropsychology
- 16 November 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186
Open AccessFrom potential to practice: An International survey on technology adoption and needs in epilepsy neuropsychology
- 13 November 2026
- Vol. 186, 111369
From potential to practice: An International survey on technology adoption and needs in epilepsy neuropsychology.
Technological integration offers opportunities to improve neuropsychological practice in epilepsy care. Compared to other healthcare fields, neuropsychology has been relatively slow to incorporate these advancements into clinical practice. To describe the use of technology in epilepsy neuropsychology and identify priorities for technological development. An online survey of multiple choice and open-ended questions was developed in English and translated into Spanish, then sent to practicing neuropsychologists working in epilepsy care across all six International League Against Epilepsy world regions. The survey collected data on the settings in which neuropsychological services are provided to people with epilepsy, the technologies currently in use, the barriers to technological adoption, and desired future developments. 179 neuropsychologists from 39 countries participated in the survey. The majority of respondents were women (69 %), aged 30-49 (60 %), and held a PhD (60 %). Key barriers to technological adoption included concerns around tool validation, financial limitations to purchase existing tools, and a lack of culturally and linguistically relevant normative data. Priorities for future development included predictive algorithms, automating psychometric aspects of clinical practice, and better leveraging of functional neuroimaging technologies. This international survey highlights that while epilepsy neuropsychologists are open to adopting new technologies in their clinical practice, there are several barriers hampering uptake across the field. Survey responses highlighted that technological developments that are practical, accessible, evidence-based, and suitable for culturally and linguistically diverse populations are required to meet the needs of the epilepsy neuropsychology workforce.
- 13 November 2026
- Vol. 186, 111369
From potential to practice: An International survey on technology adoption and needs in epilepsy neuropsychology.
Technological integration offers opportunities to improve neuropsychological practice in epilepsy care. Compared to other healthcare fields, neuropsychology has been relatively slow to incorporate these advancements into clinical practice. To describe the use of technology in epilepsy neuropsychology and identify priorities for technological development. An online survey of multiple choice and open-ended questions was developed in English and translated into Spanish, then sent to practicing neuropsychologists working in epilepsy care across all six International League Against Epilepsy world regions. The survey collected data on the settings in which neuropsychological services are provided to people with epilepsy, the technologies currently in use, the barriers to technological adoption, and desired future developments. 179 neuropsychologists from 39 countries participated in the survey. The majority of respondents were women (69 %), aged 30-49 (60 %), and held a PhD (60 %). Key barriers to technological adoption included concerns around tool validation, financial limitations to purchase existing tools, and a lack of culturally and linguistically relevant normative data. Priorities for future development included predictive algorithms, automating psychometric aspects of clinical practice, and better leveraging of functional neuroimaging technologies. This international survey highlights that while epilepsy neuropsychologists are open to adopting new technologies in their clinical practice, there are several barriers hampering uptake across the field. Survey responses highlighted that technological developments that are practical, accessible, evidence-based, and suitable for culturally and linguistically diverse populations are required to meet the needs of the epilepsy neuropsychology workforce.
- 9 January 2025
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 39 (5) , 1194-1205
ABBA Letter Alternation: A telehealth inspired measure of executive functioning/inhibitory control
Objective: To introduce ABBA Letter Alternation (ABBA) as a computerized measure of response inhibition/response alternation developed for telehealth following restrictions of in-person testing due to COVID-19. ABBA consists of two PowerPoint-administered trials: Letter Reading of 25 capital As or Bs individually presented, and Letter Alternation with instructions to say the opposite letter to what is presented. Method: We obtained initial normative ABBA performance from 899 healthy research volunteers participating in the Emory Healthy Brain Study (EHBS) with Montreal Cognitive Assessment (MoCA) scores 24/30 and higher. Cutpoints derived from the EHBS sample were applied to a series of 32 Parkinson disease (PD) patients being evaluated for deep brain stimulation to provide preliminary clinical validation. Trail Making B (TMT B) was also examined in both groups. Results: 775 (86.2%) EHBS participants made 0-1 ABBA Letter Alternation errors, 58 (6.5%) EHBS participants had 2 ABBA alternation errors, and 66 (7.3%) made 3+ errors. Applying these thresholds to PD patients, 22 (68.8%) made 0-1 alternation errors, 3 PD (9.4%) patients made 2 errors, and 7 PD subjects (21.8%) made 3+ errors, which significantly differed in frequency from the EHBS group (χ2=9.8, p=.007). EHBS vs. PD differed on MoCA, a medium effect (p<.00001; η2=.076), and on TMT B (p<.00001; η2=.158), which is considered a large effect. Conclusion: These results provide initial support for ABBA Letter Alternation as a response inhibition/response alternation. Application in larger clinical samples, in both telehealth and face-to-face settings, will be needed to more fully establish ABBA's clinical utility.
- 9 January 2025
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 39 (5) , 1194-1205
ABBA Letter Alternation: A telehealth inspired measure of executive functioning/inhibitory control
Objective: To introduce ABBA Letter Alternation (ABBA) as a computerized measure of response inhibition/response alternation developed for telehealth following restrictions of in-person testing due to COVID-19. ABBA consists of two PowerPoint-administered trials: Letter Reading of 25 capital As or Bs individually presented, and Letter Alternation with instructions to say the opposite letter to what is presented. Method: We obtained initial normative ABBA performance from 899 healthy research volunteers participating in the Emory Healthy Brain Study (EHBS) with Montreal Cognitive Assessment (MoCA) scores 24/30 and higher. Cutpoints derived from the EHBS sample were applied to a series of 32 Parkinson disease (PD) patients being evaluated for deep brain stimulation to provide preliminary clinical validation. Trail Making B (TMT B) was also examined in both groups. Results: 775 (86.2%) EHBS participants made 0-1 ABBA Letter Alternation errors, 58 (6.5%) EHBS participants had 2 ABBA alternation errors, and 66 (7.3%) made 3+ errors. Applying these thresholds to PD patients, 22 (68.8%) made 0-1 alternation errors, 3 PD (9.4%) patients made 2 errors, and 7 PD subjects (21.8%) made 3+ errors, which significantly differed in frequency from the EHBS group (χ2=9.8, p=.007). EHBS vs. PD differed on MoCA, a medium effect (p<.00001; η2=.076), and on TMT B (p<.00001; η2=.158), which is considered a large effect. Conclusion: These results provide initial support for ABBA Letter Alternation as a response inhibition/response alternation. Application in larger clinical samples, in both telehealth and face-to-face settings, will be needed to more fully establish ABBA's clinical utility.
- 22 May 2024
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 39 (1) , 218-232
A neuropsychological profile for high-grade primary central nervous system neuroendocrine tumor (CNS NET): A single-case study
Objective: Neuroendocrine tumors (NETs) are neoplasms that primarily occur in the lungs, appendix, small intestine, pancreas, and rectum, and typically metastasize to the liver or lymph nodes. However, in rare cases NETs can originate in the central nervous system (CNS). Understanding primary CNS NET neuropsychological manifestations aids in recommendations for neurocognitive follow-up, treatment and lifestyle planning, and future research. Method: Given the dearth of neuropsychological research for CNS NETs, we present a case seen in a 43-year-old woman. Results: Initial and 8-month follow-up neuropsychological evaluations of the patient revealed a Major Neurocognitive Disorder where the pattern of findings was consistent with tumor location and additional treatment-related factors. Reliable change indices at her re-evaluation revealed declines in verbal and visual memory, with statistical, yet not clinical, improvements in different domains. Follow-up monitoring of comprehensive care continued to occur after neuropsychological evaluations. Conclusions: This case study assists in the characterization of initial and follow-up neuropsychological presentation of a primary CNS NET, where evaluations helped inform clinical care and functional recommendations. This case demonstrates the importance for neuropsychologists to have awareness of various conditions, even rare conditions, which can inform a systematic approach to research and clinical care with neuro-oncological populations.
- 22 May 2024
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 39 (1) , 218-232
A neuropsychological profile for high-grade primary central nervous system neuroendocrine tumor (CNS NET): A single-case study
Objective: Neuroendocrine tumors (NETs) are neoplasms that primarily occur in the lungs, appendix, small intestine, pancreas, and rectum, and typically metastasize to the liver or lymph nodes. However, in rare cases NETs can originate in the central nervous system (CNS). Understanding primary CNS NET neuropsychological manifestations aids in recommendations for neurocognitive follow-up, treatment and lifestyle planning, and future research. Method: Given the dearth of neuropsychological research for CNS NETs, we present a case seen in a 43-year-old woman. Results: Initial and 8-month follow-up neuropsychological evaluations of the patient revealed a Major Neurocognitive Disorder where the pattern of findings was consistent with tumor location and additional treatment-related factors. Reliable change indices at her re-evaluation revealed declines in verbal and visual memory, with statistical, yet not clinical, improvements in different domains. Follow-up monitoring of comprehensive care continued to occur after neuropsychological evaluations. Conclusions: This case study assists in the characterization of initial and follow-up neuropsychological presentation of a primary CNS NET, where evaluations helped inform clinical care and functional recommendations. This case demonstrates the importance for neuropsychologists to have awareness of various conditions, even rare conditions, which can inform a systematic approach to research and clinical care with neuro-oncological populations.
- 24 April 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 155, 109669
Comparison of minimally invasive to standard temporal lobectomy approaches to epilepsy surgery: Seizure relief and visual confrontation naming outcomes
- 24 April 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 155, 109669
Comparison of minimally invasive to standard temporal lobectomy approaches to epilepsy surgery: Seizure relief and visual confrontation naming outcomes
- 4 March 2024
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 39 (6) , 747-765
The Montreal Cognitive Assessment: Norms and Reliable Change Indices for Standard and MoCA-22 Administrations
Objective: The Montreal Cognitive Assessment (MoCA) is among the most frequently administered cognitive screening tests, yet demographically diverse normative data are needed for repeated administrations. Method: Data were obtained from 18,410 participants using the National Alzheimer’s Coordinating Center Uniform Data Set. We developed regression-based norms using Tobit regression to account for ceiling effects, explored test–retest reliability of total scores and by domain stratified by age and diagnosis with Cronbach’s alpha, and reported the cumulative change frequencies for individuals with serial MoCA administrations to gage expected change. Results: Strong ceiling effects and negative skew were observed at the total score, domain, and item levels for the cognitively normal group, and performances became more normally distributed as the degree of cognitive impairment increased. In regression models, years of education was associated with higher MoCA scores, whereas older age, male sex, Black and American Indian or Alaska Native race, and Hispanic ethnicity were associated with lower predicted scores. Temporal stability was adequate and good at the total score level for the cognitively normal and cognitive disorders groups, respectively, but fell short of reliability standards at the domain level. Conclusions: MoCA total scores are adequately reproducible among those with cognitive diagnoses, but domain scores are unstable. Robust regression-based norms should be used to adjust for demographic performance differences, and the limited reliability, along with the ceiling effects and negative skew, should be considered when interpreting MoCA scores.
- 4 March 2024
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 39 (6) , 747-765
The Montreal Cognitive Assessment: Norms and Reliable Change Indices for Standard and MoCA-22 Administrations
Objective: The Montreal Cognitive Assessment (MoCA) is among the most frequently administered cognitive screening tests, yet demographically diverse normative data are needed for repeated administrations. Method: Data were obtained from 18,410 participants using the National Alzheimer’s Coordinating Center Uniform Data Set. We developed regression-based norms using Tobit regression to account for ceiling effects, explored test–retest reliability of total scores and by domain stratified by age and diagnosis with Cronbach’s alpha, and reported the cumulative change frequencies for individuals with serial MoCA administrations to gage expected change. Results: Strong ceiling effects and negative skew were observed at the total score, domain, and item levels for the cognitively normal group, and performances became more normally distributed as the degree of cognitive impairment increased. In regression models, years of education was associated with higher MoCA scores, whereas older age, male sex, Black and American Indian or Alaska Native race, and Hispanic ethnicity were associated with lower predicted scores. Temporal stability was adequate and good at the total score level for the cognitively normal and cognitive disorders groups, respectively, but fell short of reliability standards at the domain level. Conclusions: MoCA total scores are adequately reproducible among those with cognitive diagnoses, but domain scores are unstable. Robust regression-based norms should be used to adjust for demographic performance differences, and the limited reliability, along with the ceiling effects and negative skew, should be considered when interpreting MoCA scores.
- 7 July 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 145, 109332
Psychiatric changes after stereotactic laser amygdalohippocampotomy for medial temporal lobe epilepsy
- 7 July 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 145, 109332
Psychiatric changes after stereotactic laser amygdalohippocampotomy for medial temporal lobe epilepsy
- 14 June 2022
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 37 (3) , 562-576
Classification statistics of the Montreal Cognitive Assessment (MoCA): Are we interpreting the MoCA correctly?
The Montreal Cognitive Assessment (MoCA) is a common cognitive screener for detecting mild cognitive impairment (MCI). However, previously suggested cutoff scores of 26/30 and above is often critic...
- 14 June 2022
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 37 (3) , 562-576
Classification statistics of the Montreal Cognitive Assessment (MoCA): Are we interpreting the MoCA correctly?
The Montreal Cognitive Assessment (MoCA) is a common cognitive screener for detecting mild cognitive impairment (MCI). However, previously suggested cutoff scores of 26/30 and above is often critic...
- Open Access
- 1 April 2022
- Published by Wiley in Epileptic Disorders
- Vol. 24 (2) , 411-416
Electrical Wada for pre‐surgical memory testing: a case report
We report a case study of a surgical candidate, a 51‐year‐old woman with left temporal lobe epilepsy, who failed a left injection intracarotid amobarbital procedure (e.g., Wada test), scoring 0 of 8 items. This raised concerns for postoperative memory decline. However, the patient was uninterested in a neuromodulatory approach and wished to be reconsidered for surgery. A stereotactic laser amygdalohippocampotomy (SLAH) was considered, encouraging the need for an alternative test to evaluate risk of memory decline. We developed a novel approach to testing memory during stimulation of a depth electrode implanted in the hippocampus, i.e., an electric Wada. During multiple stimulation trials across a range of amplitudes, the patient scored up to 8 of 8 items, which suggested strong contralateral memory support. The surgical team proceeded with a radiofrequency ablation and a subsequent SLAH. The patient remains seizure‐free at 12 months post SLAH with no evidence of verbal or visuospatial memory decline based on a post‐surgical neuropsychological battery. We believe that this case study provides a proof of concept for the feasibility and possible utility of an electric version of the Wada procedure. Future studies are needed to develop an optimal paradigm and to validate this approach.
- 1 April 2022
- Published by Wiley in Epileptic Disorders
- Vol. 24 (2) , 411-416
Open AccessElectrical Wada for pre‐surgical memory testing: a case report
We report a case study of a surgical candidate, a 51‐year‐old woman with left temporal lobe epilepsy, who failed a left injection intracarotid amobarbital procedure (e.g., Wada test), scoring 0 of 8 items. This raised concerns for postoperative memory decline. However, the patient was uninterested in a neuromodulatory approach and wished to be reconsidered for surgery. A stereotactic laser amygdalohippocampotomy (SLAH) was considered, encouraging the need for an alternative test to evaluate risk of memory decline. We developed a novel approach to testing memory during stimulation of a depth electrode implanted in the hippocampus, i.e., an electric Wada. During multiple stimulation trials across a range of amplitudes, the patient scored up to 8 of 8 items, which suggested strong contralateral memory support. The surgical team proceeded with a radiofrequency ablation and a subsequent SLAH. The patient remains seizure‐free at 12 months post SLAH with no evidence of verbal or visuospatial memory decline based on a post‐surgical neuropsychological battery. We believe that this case study provides a proof of concept for the feasibility and possible utility of an electric version of the Wada procedure. Future studies are needed to develop an optimal paradigm and to validate this approach.
- 22 January 2022
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 36 (4) , 790-805
Diverse experiences and approaches to tele neuropsychology: Commentary and reflections over the past year of COVID-19
Objectives: In response to the coronavirus disease 2019 (COVID-19) pandemic, neuropsychologists rapidly adopted teleneuropsychology (TeleNP) services to ensure continued clinical care. Prior to COVID-19, TeleNP was not widely used nor was it included in the majority of traditional practice or training models across graduate, internship, and postdoctoral programs. Out of necessity, the pandemic was a catalyst that promoted greater adoption of TeleNP services. In response, neuropsychological guidelines for modified assessments were developed and further empirical studies have been published. Numerous surveys in response to service delivery changes during COVID-19 now exist, but what follows is a commentary based on neuropsychologists’ experiences with adapting clinical practice to TeleNP. Methods: Co-authors represent settings across academic medical centers, Veterans Affairs hospitals, and private practices that serve multiculturally diverse pediatric, adult, and geriatric populations in the United States. Results: The perspectives within this commentary aim to highlight the growth of TeleNP and highlight lessons learned from implementation across practice settings. Conclusions: Our goal is to help foster the development of further empirical studies through candid discussion of various TeleNP experiences and approaches. Through this reflective process, TeleNP presents both opportunities and challenges but it ultimately has potential to reduce healthcare disparities and enhance patient care.
- 22 January 2022
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 36 (4) , 790-805
Diverse experiences and approaches to tele neuropsychology: Commentary and reflections over the past year of COVID-19
Objectives: In response to the coronavirus disease 2019 (COVID-19) pandemic, neuropsychologists rapidly adopted teleneuropsychology (TeleNP) services to ensure continued clinical care. Prior to COVID-19, TeleNP was not widely used nor was it included in the majority of traditional practice or training models across graduate, internship, and postdoctoral programs. Out of necessity, the pandemic was a catalyst that promoted greater adoption of TeleNP services. In response, neuropsychological guidelines for modified assessments were developed and further empirical studies have been published. Numerous surveys in response to service delivery changes during COVID-19 now exist, but what follows is a commentary based on neuropsychologists’ experiences with adapting clinical practice to TeleNP. Methods: Co-authors represent settings across academic medical centers, Veterans Affairs hospitals, and private practices that serve multiculturally diverse pediatric, adult, and geriatric populations in the United States. Results: The perspectives within this commentary aim to highlight the growth of TeleNP and highlight lessons learned from implementation across practice settings. Conclusions: Our goal is to help foster the development of further empirical studies through candid discussion of various TeleNP experiences and approaches. Through this reflective process, TeleNP presents both opportunities and challenges but it ultimately has potential to reduce healthcare disparities and enhance patient care.